Leukoagglutinins in patients with hemophilia

Anti-leukocyte antibodies may occur in hemophilic patients as a consequence of replacement therapy with blood derivatives. In this report we describe the presence of leukoagglutinis (LA) in serum of HIV-infected hemophiliacs (HIV+He) and their absence in HIV-negative patients (HIVHe). LA activity w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Immunology letters 1990-05, Vol.24 (2), p.107-111
Hauptverfasser: Riera, Norma E., Galassi, Nora, Anselmo, Armando, Aixala, Monica, Bouza, Maria B., de Bracco, Maria M.E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 111
container_issue 2
container_start_page 107
container_title Immunology letters
container_volume 24
creator Riera, Norma E.
Galassi, Nora
Anselmo, Armando
Aixala, Monica
Bouza, Maria B.
de Bracco, Maria M.E.
description Anti-leukocyte antibodies may occur in hemophilic patients as a consequence of replacement therapy with blood derivatives. In this report we describe the presence of leukoagglutinis (LA) in serum of HIV-infected hemophiliacs (HIV+He) and their absence in HIV-negative patients (HIVHe). LA activity was recovered in IgG fractions from HIV+He, in the polyethylene glycol (PEG) precipitates from these sera, and in some cases in the supernatant fractions of PEG precipitates. Although the amount of PEG precipitates corresponding to circulating immune complexes (CIC) was higher in HIV+He than in HIV-He and normals, there was no direct relationship between CIC levels and LA. LA reacted both with autologous and with allogeneic polymorphonuclear leukocytes (PMN). In contrast to PMN isolated from HIV-He, HIV+He PMN had membrane associated IgG. In HIV+He, LA activity was more frequently observed in patients with more advanced stages of HIV infection than in asymptomatic individuals. Our results suggest that LA activity could be one of the manifestations of autoreactivity associated with progressing HIV infection in patients with hemophilia.
doi_str_mv 10.1016/0165-2478(90)90020-Q
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79837938</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>016524789090020Q</els_id><sourcerecordid>79837938</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-73a4ef75f98f180643be4f26e3665fbea8ae8ffb492b55cf90b2258afa342ea03</originalsourceid><addsrcrecordid>eNp9kEtLxDAQx4Mo6_r4Bgo9iChYTfNok4sgiy9YkAU9hzQ72Y32ZdIqfntbt-zRwzCH-f1nhh9CJwm-TnCS3vTFY8IycSHxpcSY4Hixg6aJyGSMOSO7aLpF9tFBCO8YJ5wyOkETQjkTKZ2iqzl0H7VerYqudZWrQuSqqNGtg6oN0bdr19EayrpZu8LpI7RndRHgeOyH6O3h_nX2FM9fHp9nd_PYUJG2cUY1A5txK4VNBE4ZzYFZkgJNU25z0EKDsDZnkuScGytxTggX2mrKCGhMD9H5Zm_j688OQqtKFwwUha6g7oLKpKCZpKIH2QY0vg7Bg1WNd6X2PyrBapCkBgNqMKAkVn-S1KKPnY77u7yE5TY0WunnZ-NcB6ML63VlXNhiqSSUJMP12w0GvYsvB14F03szsHQeTKuWtfv_j1_sU4Kx</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79837938</pqid></control><display><type>article</type><title>Leukoagglutinins in patients with hemophilia</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Riera, Norma E. ; Galassi, Nora ; Anselmo, Armando ; Aixala, Monica ; Bouza, Maria B. ; de Bracco, Maria M.E.</creator><creatorcontrib>Riera, Norma E. ; Galassi, Nora ; Anselmo, Armando ; Aixala, Monica ; Bouza, Maria B. ; de Bracco, Maria M.E.</creatorcontrib><description>Anti-leukocyte antibodies may occur in hemophilic patients as a consequence of replacement therapy with blood derivatives. In this report we describe the presence of leukoagglutinis (LA) in serum of HIV-infected hemophiliacs (HIV+He) and their absence in HIV-negative patients (HIVHe). LA activity was recovered in IgG fractions from HIV+He, in the polyethylene glycol (PEG) precipitates from these sera, and in some cases in the supernatant fractions of PEG precipitates. Although the amount of PEG precipitates corresponding to circulating immune complexes (CIC) was higher in HIV+He than in HIV-He and normals, there was no direct relationship between CIC levels and LA. LA reacted both with autologous and with allogeneic polymorphonuclear leukocytes (PMN). In contrast to PMN isolated from HIV-He, HIV+He PMN had membrane associated IgG. In HIV+He, LA activity was more frequently observed in patients with more advanced stages of HIV infection than in asymptomatic individuals. Our results suggest that LA activity could be one of the manifestations of autoreactivity associated with progressing HIV infection in patients with hemophilia.</description><identifier>ISSN: 0165-2478</identifier><identifier>EISSN: 1879-0542</identifier><identifier>DOI: 10.1016/0165-2478(90)90020-Q</identifier><identifier>PMID: 2354863</identifier><identifier>CODEN: IMLED6</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Adolescent ; Adult ; AIDS/HIV ; Anti-leukocyte antibody ; Antigen-Antibody Complex - analysis ; Autoantibodies - biosynthesis ; Autoimmunity ; Biological and medical sciences ; Child ; Circulating immune complex ; Haemophilia ; Hemophilia A - complications ; Hemophilia A - immunology ; HIV infection ; HIV Seropositivity - complications ; HIV Seropositivity - immunology ; Humans ; Immunodeficiencies ; Immunodeficiencies. Immunoglobulinopathies ; Immunoglobulin G - biosynthesis ; Immunoglobulin G - immunology ; Immunopathology ; Leukoagglutinins ; Leukocytes - immunology ; Medical sciences ; Neutrophils - immunology</subject><ispartof>Immunology letters, 1990-05, Vol.24 (2), p.107-111</ispartof><rights>1990</rights><rights>1990 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-73a4ef75f98f180643be4f26e3665fbea8ae8ffb492b55cf90b2258afa342ea03</citedby><cites>FETCH-LOGICAL-c386t-73a4ef75f98f180643be4f26e3665fbea8ae8ffb492b55cf90b2258afa342ea03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0165-2478(90)90020-Q$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=6923218$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2354863$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Riera, Norma E.</creatorcontrib><creatorcontrib>Galassi, Nora</creatorcontrib><creatorcontrib>Anselmo, Armando</creatorcontrib><creatorcontrib>Aixala, Monica</creatorcontrib><creatorcontrib>Bouza, Maria B.</creatorcontrib><creatorcontrib>de Bracco, Maria M.E.</creatorcontrib><title>Leukoagglutinins in patients with hemophilia</title><title>Immunology letters</title><addtitle>Immunol Lett</addtitle><description>Anti-leukocyte antibodies may occur in hemophilic patients as a consequence of replacement therapy with blood derivatives. In this report we describe the presence of leukoagglutinis (LA) in serum of HIV-infected hemophiliacs (HIV+He) and their absence in HIV-negative patients (HIVHe). LA activity was recovered in IgG fractions from HIV+He, in the polyethylene glycol (PEG) precipitates from these sera, and in some cases in the supernatant fractions of PEG precipitates. Although the amount of PEG precipitates corresponding to circulating immune complexes (CIC) was higher in HIV+He than in HIV-He and normals, there was no direct relationship between CIC levels and LA. LA reacted both with autologous and with allogeneic polymorphonuclear leukocytes (PMN). In contrast to PMN isolated from HIV-He, HIV+He PMN had membrane associated IgG. In HIV+He, LA activity was more frequently observed in patients with more advanced stages of HIV infection than in asymptomatic individuals. Our results suggest that LA activity could be one of the manifestations of autoreactivity associated with progressing HIV infection in patients with hemophilia.</description><subject>Adolescent</subject><subject>Adult</subject><subject>AIDS/HIV</subject><subject>Anti-leukocyte antibody</subject><subject>Antigen-Antibody Complex - analysis</subject><subject>Autoantibodies - biosynthesis</subject><subject>Autoimmunity</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Circulating immune complex</subject><subject>Haemophilia</subject><subject>Hemophilia A - complications</subject><subject>Hemophilia A - immunology</subject><subject>HIV infection</subject><subject>HIV Seropositivity - complications</subject><subject>HIV Seropositivity - immunology</subject><subject>Humans</subject><subject>Immunodeficiencies</subject><subject>Immunodeficiencies. Immunoglobulinopathies</subject><subject>Immunoglobulin G - biosynthesis</subject><subject>Immunoglobulin G - immunology</subject><subject>Immunopathology</subject><subject>Leukoagglutinins</subject><subject>Leukocytes - immunology</subject><subject>Medical sciences</subject><subject>Neutrophils - immunology</subject><issn>0165-2478</issn><issn>1879-0542</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1990</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtLxDAQx4Mo6_r4Bgo9iChYTfNok4sgiy9YkAU9hzQ72Y32ZdIqfntbt-zRwzCH-f1nhh9CJwm-TnCS3vTFY8IycSHxpcSY4Hixg6aJyGSMOSO7aLpF9tFBCO8YJ5wyOkETQjkTKZ2iqzl0H7VerYqudZWrQuSqqNGtg6oN0bdr19EayrpZu8LpI7RndRHgeOyH6O3h_nX2FM9fHp9nd_PYUJG2cUY1A5txK4VNBE4ZzYFZkgJNU25z0EKDsDZnkuScGytxTggX2mrKCGhMD9H5Zm_j688OQqtKFwwUha6g7oLKpKCZpKIH2QY0vg7Bg1WNd6X2PyrBapCkBgNqMKAkVn-S1KKPnY77u7yE5TY0WunnZ-NcB6ML63VlXNhiqSSUJMP12w0GvYsvB14F03szsHQeTKuWtfv_j1_sU4Kx</recordid><startdate>19900501</startdate><enddate>19900501</enddate><creator>Riera, Norma E.</creator><creator>Galassi, Nora</creator><creator>Anselmo, Armando</creator><creator>Aixala, Monica</creator><creator>Bouza, Maria B.</creator><creator>de Bracco, Maria M.E.</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19900501</creationdate><title>Leukoagglutinins in patients with hemophilia</title><author>Riera, Norma E. ; Galassi, Nora ; Anselmo, Armando ; Aixala, Monica ; Bouza, Maria B. ; de Bracco, Maria M.E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-73a4ef75f98f180643be4f26e3665fbea8ae8ffb492b55cf90b2258afa342ea03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1990</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>AIDS/HIV</topic><topic>Anti-leukocyte antibody</topic><topic>Antigen-Antibody Complex - analysis</topic><topic>Autoantibodies - biosynthesis</topic><topic>Autoimmunity</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Circulating immune complex</topic><topic>Haemophilia</topic><topic>Hemophilia A - complications</topic><topic>Hemophilia A - immunology</topic><topic>HIV infection</topic><topic>HIV Seropositivity - complications</topic><topic>HIV Seropositivity - immunology</topic><topic>Humans</topic><topic>Immunodeficiencies</topic><topic>Immunodeficiencies. Immunoglobulinopathies</topic><topic>Immunoglobulin G - biosynthesis</topic><topic>Immunoglobulin G - immunology</topic><topic>Immunopathology</topic><topic>Leukoagglutinins</topic><topic>Leukocytes - immunology</topic><topic>Medical sciences</topic><topic>Neutrophils - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Riera, Norma E.</creatorcontrib><creatorcontrib>Galassi, Nora</creatorcontrib><creatorcontrib>Anselmo, Armando</creatorcontrib><creatorcontrib>Aixala, Monica</creatorcontrib><creatorcontrib>Bouza, Maria B.</creatorcontrib><creatorcontrib>de Bracco, Maria M.E.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Immunology letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Riera, Norma E.</au><au>Galassi, Nora</au><au>Anselmo, Armando</au><au>Aixala, Monica</au><au>Bouza, Maria B.</au><au>de Bracco, Maria M.E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Leukoagglutinins in patients with hemophilia</atitle><jtitle>Immunology letters</jtitle><addtitle>Immunol Lett</addtitle><date>1990-05-01</date><risdate>1990</risdate><volume>24</volume><issue>2</issue><spage>107</spage><epage>111</epage><pages>107-111</pages><issn>0165-2478</issn><eissn>1879-0542</eissn><coden>IMLED6</coden><abstract>Anti-leukocyte antibodies may occur in hemophilic patients as a consequence of replacement therapy with blood derivatives. In this report we describe the presence of leukoagglutinis (LA) in serum of HIV-infected hemophiliacs (HIV+He) and their absence in HIV-negative patients (HIVHe). LA activity was recovered in IgG fractions from HIV+He, in the polyethylene glycol (PEG) precipitates from these sera, and in some cases in the supernatant fractions of PEG precipitates. Although the amount of PEG precipitates corresponding to circulating immune complexes (CIC) was higher in HIV+He than in HIV-He and normals, there was no direct relationship between CIC levels and LA. LA reacted both with autologous and with allogeneic polymorphonuclear leukocytes (PMN). In contrast to PMN isolated from HIV-He, HIV+He PMN had membrane associated IgG. In HIV+He, LA activity was more frequently observed in patients with more advanced stages of HIV infection than in asymptomatic individuals. Our results suggest that LA activity could be one of the manifestations of autoreactivity associated with progressing HIV infection in patients with hemophilia.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>2354863</pmid><doi>10.1016/0165-2478(90)90020-Q</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0165-2478
ispartof Immunology letters, 1990-05, Vol.24 (2), p.107-111
issn 0165-2478
1879-0542
language eng
recordid cdi_proquest_miscellaneous_79837938
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Adolescent
Adult
AIDS/HIV
Anti-leukocyte antibody
Antigen-Antibody Complex - analysis
Autoantibodies - biosynthesis
Autoimmunity
Biological and medical sciences
Child
Circulating immune complex
Haemophilia
Hemophilia A - complications
Hemophilia A - immunology
HIV infection
HIV Seropositivity - complications
HIV Seropositivity - immunology
Humans
Immunodeficiencies
Immunodeficiencies. Immunoglobulinopathies
Immunoglobulin G - biosynthesis
Immunoglobulin G - immunology
Immunopathology
Leukoagglutinins
Leukocytes - immunology
Medical sciences
Neutrophils - immunology
title Leukoagglutinins in patients with hemophilia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T22%3A18%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Leukoagglutinins%20in%20patients%20with%20hemophilia&rft.jtitle=Immunology%20letters&rft.au=Riera,%20Norma%20E.&rft.date=1990-05-01&rft.volume=24&rft.issue=2&rft.spage=107&rft.epage=111&rft.pages=107-111&rft.issn=0165-2478&rft.eissn=1879-0542&rft.coden=IMLED6&rft_id=info:doi/10.1016/0165-2478(90)90020-Q&rft_dat=%3Cproquest_cross%3E79837938%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79837938&rft_id=info:pmid/2354863&rft_els_id=016524789090020Q&rfr_iscdi=true